BUY Torrent Pharmaceuticals Limited — Shrikant Chouhan, Kotak Securities
byShrikant Chouhan, Kotak SecuritiesHorizon: 1–3 months25 Sept 2026via Zee Business (Live)
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Torrent Pharmaceuticals stock reports 54.6 percent sales growth
NewsGoogle News·25 Sept · 2d ago
4 advisors have active long-term BUY calls on this stock, with 1 issued in the last 14 days
Advisor consensus · adjacent horizon·22 Sept · 6d ago
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Torrent Pharmaceuticals
- BUY — Rajesh Satpute9 Nov 2026 · ~2 weeks · target ₹4,900 · SL hit
- BUY — Aastha Jain, Hem Securities6 Nov 2026 · Next day · target ₹4,840 · Expired
- BUY — Geojit Financial Services5 Nov 2026 · ~1 year · target ₹5,581 · Active
- BUY — Sandeep Jain, Tradeswift2 Nov 2026 · ~2 weeks · target ₹4,970 · Active
- BUY — Citigroup26 Oct 2026 · ~1 year · target ₹5,860 · Active
More from Shrikant Chouhan, Kotak Securities
- BUY Manappuram Finance13 Nov 2026 · ~2 weeks · target ₹340 · Active
- BUY Bajaj Finance13 Nov 2026 · ~2 weeks · target ₹1,150 · Active
- BUY Prestige Estates Projects13 Nov 2026 · ~2 weeks · target ₹1,750 · SL hit
- BUY One 97 Communications12 Nov 2026 · Next day · target ₹2,000 · Active
- BUY Steel Authority of India12 Nov 2026 · ~2 weeks · target ₹190 · Active

